Literature DB >> 19899032

Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection.

Y Tamiya1, K Nakahara, K Kominato, O Serikawa, Y Watanabe, H Tateishi, H Takedatsu, A Toyonaga, M Sata.   

Abstract

BACKGROUND AND STUDY AIM: Esophageal perforation caused by endoscopic submucosal dissection (ESD) induces serious pneumomediastinum. In the absence of endoscopically detected perforation, postprocedural pneumomediastinum may occur. The aim of this study was to evaluate the association between the clinical factors/courses and pneumomediastinum revealed by chest computed tomography (CT) with special reference to an exposed muscle layer during esophageal ESD. PATIENTS AND METHODS: A total of 58 patients undergoing ESD for esophageal neoplasms between February 2003 and June 2007 also underwent both chest radiography and chest CT within 1 hour after ESD. We studied the association between findings on CT scan and tumor-related and technical factors of esophageal ESD by uni- and multivariate analyses. We also analyzed the clinical factors/courses experienced by all patients.
RESULTS: Pneumomediastinum was detected in 18 / 58 patients (31 %) by chest CT compared with only 1 / 58 patients (1.7 %) by chest radiography. ESD-induced exposure of the muscular layer (32 patients) was the only significant factor for pneumomediastinum (18 / 32; P < 0.0001). Clinical factors such as fever, white blood cell count, and C-reactive protein were significantly increased in the group positive for both endoscopically exposed muscular layer and pneumomediastinum (+/+, n = 18) compared with the (-/-) group (n = 26) in the early phase (day 1) after ESD. However, these factors did not affect the length of the fasting period or the length of hospital stay.
CONCLUSIONS: In esophageal ESD, pneumomediastinum detected by chest CT only does not cause clinically significant complication. Endoscopic muscle exposure during ESD is a significant risk factor for pneumomediastinum, which causes mild inflammation in the early post-ESD phase. Georg Thieme Verlag KG Stuttgart. New York.

Entities:  

Mesh:

Year:  2009        PMID: 19899032     DOI: 10.1055/s-0029-1215215

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  19 in total

1.  Endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms.

Authors:  Kuniomi Honda; Hirotada Akiho
Journal:  World J Gastrointest Pathophysiol       Date:  2012-04-15

Review 2.  Endoscopic submucosal dissection for malignant esophageal lesions.

Authors:  Hazem Hammad; Tonya Kaltenbach; Roy Soetikno
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 3.  Peroral endoscopic myotomy: an evolving treatment for achalasia.

Authors:  Robert Bechara; Haruo Ikeda; Haruhiro Inoue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-02       Impact factor: 46.802

4.  Clinical significance of intraperitoneal air on computed tomography scan after endoscopic submucosal dissection in patients with gastric neoplasms.

Authors:  Soo-Jeong Cho; Il Ju Choi; Soo Jin Kim; Min Ju Kim; Chan Gyoo Kim; Jong Yeul Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

Review 5.  Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis.

Authors:  Joon Sung Kim; Byung-Wook Kim; In-Soo Shin
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

6.  The low incidence of bacteremia after esophageal endoscopic submucosal dissection (ESD) obviates the need for prophylactic antibiotics in esophageal ESD.

Authors:  Noboru Kawata; Masaki Tanaka; Naomi Kakushima; Kohei Takizawa; Kenichiro Imai; Kinichi Hotta; Hiroyuki Matsubayashi; Mika Tsukahara; Ichiro Kawamura; Hanako Kurai; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2016-03-16       Impact factor: 4.584

7.  Carbon dioxide insufflation in esophageal endoscopic submucosal dissection reduces mediastinal emphysema: A randomized, double-blind, controlled trial.

Authors:  Yuki Maeda; Dai Hirasawa; Naotaka Fujita; Tetsuya Ohira; Yoshihiro Harada; Taku Yamagata; Yoshiki Koike; Kenjirou Suzuki
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia.

Authors:  Bing-Rong Liu; Ji-Tao Song; Ling-Jian Kong; Feng-Hua Pei; Xin-Hong Wang; Ya-Ju Du
Journal:  Surg Endosc       Date:  2013-06-14       Impact factor: 4.584

9.  Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria.

Authors:  Bing-Rong Liu; Ji-Tao Song; Bo Qu; Ji-Feng Wen; Ji-Bin Yin; Wei Liu
Journal:  Surg Endosc       Date:  2012-05-12       Impact factor: 4.584

10.  Endoscopic submucosal dissection and surgical treatment for gastrointestinal cancer.

Authors:  Michio Asano
Journal:  World J Gastrointest Endosc       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.